Accuracy of detecting residual disease after cross neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol - Noordman, B J; Shapiro, J; Spaander, M C (JMIR Res Protoc, 2015)
et al.